We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Budesonide

News List

Bulk Price and Chinese manufacturers of Budesonide API Powder PharmaSources
July 13, 2021
Budesonide is a corticosteroid with anti-inflammatory and immunomodulating effects.
Inhaled asthma drug accelerates recovery from COVID-19 pharmatimes
April 13, 2021
The inhaled corticosteroid medication budesonide, widely used for the treatment of asthma, has been found to aid the recovery of COVID-19 patients when administered at home.
Nephron Receives Warning Letter from FDA americanpharmaceuticalreview
October 12, 2020
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Nephron Pharmaceuticals Corporation due to emails Nephron’s CEO and a sales representative sent concerning its product Budesonide Inhalation Suspension ...
UK launch for first eosinophilic oesophagitis drug pharmatimes
October 19, 2018
Dr Falk Pharma has launched Jorveza - the first globally licensed drug approved for eosinophilic oesophagitis - across the UK.